en · de · es · fr · pt
melanotan-2-notes.peptides9002.com › Topic › Storage, Verification And Regulatory Status — Explained

Storage, Verification And Regulatory Status — Explained

By Editorial Desk · published 2026-07-20 · last reviewed 2026-08-01 · Topic

mass spectrometry comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.

Storage, Verification and Regulatory Status

Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.

Freeze-dried melanotan-2 is normally kept as a desiccated powder at minus twenty degrees Celsius or lower, shielded from light and moisture. Peptides of this size degrade through hydrolysis, oxidation and deamidation, and each pathway accelerates as temperature and water activity rise. Repeated freeze-thaw cycles promote aggregation and loss of material, so aliquoting a stock solution before freezing is standard laboratory practice. Once dissolved, the solution is markedly less stable than the powder. In laboratory work, solutions are generally refrigerated and used within days rather than kept for months.

Chemistry and Receptor Pharmacology

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Melanotan-2 at a glance

PropertyValueNotes
Typical storage temperature-20 °C or belowFor the lyophilised powder, desiccated
Storage formSealed vial, protected from lightAmber glass or foil-wrapped containers
Reconstituted stabilityShort, refrigerateDegradation accelerates in solution
Typical analytical methodReversed-phase HPLC with mass spectrometryPurity assessment plus identity confirmation
Common synonymsMelanotan II, MT-IIAlso written melanotan-2

Handling, Storage, and Analytical Verification

Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.

Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.

Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.

Related pages on this site

Peptide Identity and Structural Background

Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.

The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.

Regulation, Literature and Verification

Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.

Because the substance circulates mainly through informal markets, verification is a recurring theme in technical discussion. Independent analyses have found that labeled content and actual content can diverge, and that purity varies between samples. Analytical laboratories use reversed-phase chromatography to separate components and mass spectrometry to confirm identity. Isotope-labeled internal standards improve quantification in complex matrices. Such methods describe what a sample contains but say nothing about its sterility, lawful status, or suitability for any use. Open questions remain about how consistently testing is applied across the supply chain.

Regulatory treatment of this peptide varies by country. It holds no marketing authorization as a medicine in the United States, the European Union, or most other jurisdictions. Some countries classify products containing it as prescription-only or unlicensed medicines, which restricts lawful supply. Authorities have issued public notices warning that unregulated products may contain undeclared or incorrect ingredients. The molecule also appears on prohibited lists for competitive sport. These measures address supply oversight rather than any approved therapeutic role.

Notes from published material

== History == Peptide amphiphiles were developed in the 1990s. They were first described by the group of Matthew Tirrell in 1995. These first reported PA molecules were composed of two domains: one of lipophilic character and another of hydrophilic properties, which allowed self-assembly into sphere-like supramolecular structures as a result of the association of the lipophilic domains away from the solvent (hydrophobic effect), which resulted in the core of the nanostructure. The hydrophilic residues become exposed to the water, giving rise to a soluble nanostructure. Work in the laboratory of Samuel I. Stupp by Hartgerink et al., in the early 2000s, reported a new type of PA that are able to self-assemble into elongated nanostructures. These novel PAs contain three regions: a hydrophobic tail, a region of beta-sheet-forming amino acids, and a charged peptide epitope designed to allow solubility of the molecule in water. In addition, the PAs may contain a targeting or signaling epitope that allows the formed nanostructures to perform a biological function, either targeting or signaling, by interacting with living systems. The self-assembly mechanism of these PAs is a combination of hydrogen-bonding between beta-sheet forming amino acids and hydrophobic collapse of the tails to yield the formation of cylindrical micelles that present the peptide epitope at extremely high density at the nanofiber surface. By changing pH or adding counterions to screen the charged surfaces of fibers, gels can be formed.

Acne necrotica Acquired generalized hypertrichosis (acquired hypertrichosis lanuginosa, hypertrichosis lanuginosa acquisita) Acquired perforating dermatosis (acquired perforating collagenosis) Acrokeratosis paraneoplastica of Bazex (acrokeratosis neoplastica, Bazex syndrome) Acroosteolysis Acute paronychia Alopecia areata Alopecia neoplastica Anagen effluvium Androgenic alopecia (androgenetic alopecia) Anhidrosis (hypohidrosis) Anonychia Apparent leukonychia Beau's lines Blue nails Bromidrosis (apocrine bromhidrosis, fetid sweat, malodorous sweating, osmidrosis) Bubble hair deformity Central centrifugal cicatricial alopecia (follicular degeneration syndrome, pseudopelade of the central scalp) Chevron nail (herringbone nail) Chromhidrosis (colored sweat) Chronic paronychia Cicatricial alopecia Clubbing (drumstick fingers, Hippocratic fingers, watch-glass nails) Congenital onychodysplasia of the index fingers Disseminate and recurrent infundibulofolliculitis Erosive pustular dermatitis of the scalp (erosive pustular dermatosis of the scalp) Erythromelanosis follicularis faciei et colli Folliculitis decalvans Folliculitis nares perforans Fox–Fordyce disease Frontal fibrosing alopecia Generalized congenital hypertrichosis (congenital hypertrichosis lanuginosa) Generalized hyperhidrosis Graham-Little syndrome Granulosis rubra nasi Green nails Gustatory hyperhidrosis Hair casts (pseudonits) Hair follicle nevus (vellus hamartoma) Hairy palms and soles Half and half nails (Lindsay's nails) Hangnail Hapalonychia Hematidrosis Hirsutism Hook nail Hot comb alopecia Hypertrichosis cubiti (hairy elbow syndrome) Hypertrichosis simplex of the scalp Intermittent hair–follicle dystrophy Keratosis pilaris atrophicans Kinking hair (acquired progressive kinking) Koenen's tumor (Koenen's periungual fibroma, periungual fibroma) Koilonychia (spoon nails) Kyrle disease Leukonychia (white nails) Lichen planopilaris (acuminatus, follicular lichen planus, lichen planus follicularis, peripilaris) Lichen planus of the nails Lichen spinulosus (keratosis spinulosa) Lipedematous alopecia (lipedematous scalp) Localized acquired hypertrichosis Localized congenital hypertrichosis Longitudinal erythronychia Longitudinal melanonychia Loose anagen syndrome (loose anagen hair syndrome) Lupus erythematosus Madarosis Malalignment of the nail plate Male-pattern baldness Marie–Unna hereditary hypotrichosis (Marie–Unna hypotrichosis) Median nail dystrophy (dystrophia unguis mediana canaliformis, median canaliform dystrophy of Heller, solenonychia) Mees' lines Melanonychia Menkes kinky hair syndrome (kinky hair disease, Menkes disease) Monilethrix (beaded hair) Muehrcke's nails (Muehrcke's lines) Nail–patella syndrome (Fong syndrome, hereditary osteoonychodysplasia, HOOD syndrome) Neoplasms of the nailbed Nevoid hypertrichosis Noncicatricial alopecia Onychauxis Onychoatrophy Onychocryptosis (ingrown nail, unguis incarnatus) Onychogryphosis (ram's horn nails) Onycholysis Onychomadesis Onychomatricoma Onychophagia (nail biting) Onychophosis Onychoptosis defluvium (alopecia unguium) Onychorrhexis (brittle nails) Onychoschizia Onychotillomania Ophiasis Palmoplantar hyperhidrosis (emotional hyperhidrosis) Parakeratosis pustulosa Patterned acquired hypertrichosis Perforating folliculitis Pili annulati (ringed hair) Pili bifurcati Pili multigemini Pili pseudoannulati (pseudo pili annulati) Pili torti (twisted hairs) Pincer nails (omega nails, trumpet nails) Pityriasis amiantacea (tinea amiantacea) Platonychia Plica neuropathica (felted hair) Plummer's nail Premature greying of hair Prepubertal hypertrichosis Pressure alopecia (postoperative alopecia, pressure-induced alopecia) Pseudofolliculitis barbae (barber's itch, folliculitis barbae traumatica, razor bumps, scarring pseudofolliculitis of the beard, shave bumps) Pseudopelade of Brocq (alopecia cicatrisata) Psoriatic nails Pterygium inversum unguis (pterygium inversus unguis, ventral pterygium) Pterygium unguis (dorsal pterygium) Purpura of the nail bed Racquet nail (brachyonychia, nail en raquette, racquet thumb) Recurrent palmoplantar hidradenitis (idiopathic palmoplantar hidradenitis, idiopathic plantar hidradenitis, painful plantar erythema, palmoplantar eccrine hidradenitis, plantar panniculitis) Red lunulae Ross' syndrome Rubinstein–Taybi syndrome Setleis syndrome Shell nail syndrome Short anagen syndrome Splinter hemorrhage Spotted lunulae Staining of the nail plate Subungual hematoma Telogen effluvium Terry's nails Traction alopecia Traumatic alopecia Traumatic anserine folliculosis Triangular alopecia (temporal alopecia, temporal triangular alopecia) Trichomegaly Trichomycosis axillaris Trichorrhexis invaginata (bamboo hair) Trichorrhexis nodosa Trichostasis spinulosa Tufted folliculitis Tumor alopecia Twenty-nail dystrophy (sandpapered nails, trachyonychia) Uncombable hair syndrome (cheveux incoiffable, pili trianguli et canaliculi, spun-glass hair) Wooly hair nevus (woolly hair nevus) X-linked hypertrichosis

=== Food Industry === Acid dyes can also be used as food colouring, helping to increase the attractiveness of certain foods, and thus becoming more appealing to customers. Some examples include erythrosine (red-pink), tartrazine (yellow), sunset yellow, and allura red, to name a few, many of which are azo dyes. These dyes can be used in frosting, cookies, bread, condiments or drinks. In order to prevent health hazards, a dye must be approved for consumption before it can be marked as edible. Some separation methods that can be used to identify unapproved dyes include the solid phase extraction process, the overpressured thin layer chromatography process, and the use of reversed-phase plates.

=== GGQ motif === The GGQ motif is a conserved amino acid sequence in release factors through all domains of life. The GGQ site consists of two glycine amino acids followed by a glutamine. In eRF1, the GGQ site is on residues 183-185 of the polypeptide, which is located on Domain 2. The distant orientation of the GGQ site is stabilized by the hydrophobic effects of neighboring amino acid residues such as leucine 176, proline 177, phenylalanine 190, and leucine 193. The gln185 residue of the GGC motif is thought to be the main catalytic site for the hydrolysis of the peptidyl-tRNA ester bond in the peptidyl transferase of the ribosome. The GGQ site is not associated with any functions of stop codon recognition, ribosomal docking, or eRF3 binding.

=== Pricing and Profits === Throughout B.P.C. control, significant profits were made. In 1948, revenues from the island's phosphate reached $745,000. As the B.P.C. was controlled by its partner governments and was a major supplier of phosphate, it had an effective monopoly over the supply of phosphate to the markets in Australia and New Zealand, and could determine the price of phosphate delivered to those markets. The B.P.C. tied the pice for Ocean Island phosphate to the price paid for Nauru phosphate, however, the BPC would vary the price paid for phosphate. For example, around 1970, Nauru phosphate was sold to Japan at $14 and $15 a ton, but sold into the markets in Australia and New Zealand at $12.30.

Sources: en.wikipedia.org

Further detail

The term supermolecule (or supramolecule) was introduced by Karl Lothar Wolf et al. (Übermoleküle) in 1937 to describe hydrogen-bonded acetic acid dimers. The term supermolecule is also used in biochemistry to describe complexes of biomolecules, such as peptides and oligonucleotides composed of multiple strands. Eventually, chemists applied these concepts to synthetic systems. One breakthrough came in the 1960s with the synthesis of the crown ethers by Charles J. Pedersen. Following this work, other researchers such as Donald J. Cram, Jean-Marie Lehn and Fritz Vögtle reported a variety of three-dimensional receptors, and throughout the 1980s research in the area gathered a rapid pace with concepts such as mechanically interlocked molecular architectures emerging. The influence of supramolecular chemistry was established by the 1987 Nobel Prize for Chemistry which was awarded to Donald J. Cram, Jean-Marie Lehn, and Charles J. Pedersen in recognition of their work in this area. The development of selective "host–guest" complexes in particular, in which a host molecule recognizes and selectively binds a certain guest, was cited as an important contribution.

Psilocybe cubensis grows naturally in tropical and subtropical conditions, often near cattle due to the ideal conditions they provide for the growth of the fungus. The cow usually consumes grains or grass covered with the spores of P. cubensis and the fungus will begin to germinate within the dung. Mushrooms such as Psilocybe cubensis are relatively easy to cultivate indoors. First, spores are inoculated within sterilized jars or bags, colloquially known as grainspawn, containing a form of carbohydrate nutrient such as rye or milo gains. After approximately one month, the spores fully colonize the grain spawn forming dense mycelium, which is then mixed within a bulk substrate such as a coconut husk fiber and vermiculite mixture. Given proper humidity, temperature, and fresh air exchange, the substrate will produce fruiting Psilocybe cubensis bodies within a month of planting. To preserve potency after harvesting, growers often dehydrate the fruit and store them in air-tight containers in cool environments. A study conducted in 2009 showed that mushrooms grown in the dark had higher levels of psilocybin and psilocin compared to the mushrooms grown in bright, indirect light, which had minimum levels. Studies were conducted where an environmentally controlled wind tunnel and a computer program were used to determine the influence of humidity on the individual basidiocarps of P. cubensis which aided in mapping their growth and development.

== Synthesis == PFOA has two main synthesis routes, electrochemical fluorination (ECF) and telomerization. The ECF route sees octanoyl chloride (the acid chloride of octanoic acid) reacted with hydrofluoric acid. Multiple products are formed by ECF with the target acid fluoride F(CF2)7COF being produced as only 10–15% of the yield, while the main products are perfluorinated cyclic ether isomers, including FC-75. This acid fluoride is hydrolyzed to yield PFOA as a mixture of straight-chain (78%), terminally branched (13%), and internally branched (9%) molecules, because ECF induces rearrangements in the carbon tail of the acid chloride. ECF also results in production wastes. 3M synthesized ECF PFOA at their Cottage Grove, Minnesota facility from 1947 to 2002 and was the world's largest producer. ECF production continues on a smaller scale in Europe and Asia. PFOA is also synthesized by the telomerization represented below, where the telogen is the organoiodine compound and the taxogen is the tetrafluoroethylene. Each step is an addition reaction where the carbon-iodine bond of the telogen is added across the carbon-carbon double bond of the unsaturated taxogen, resulting in the formation of a new telogen.

=== Higher education === During his 2022 gubernatorial campaign, Moore called a plan to cancel up to $20,000 in federal student loan debt a "good first step" and said he would push the Biden administration to forgive more federal student debt if elected governor. In June 2023, Moore opposed the U.S. Supreme Court's ruling in Students for Fair Admissions v. Harvard, which held that race-based affirmative action in college admissions violated the Equal Protection Clause, calling it a "misguided ruling". In April 2024, Moore signed into law a bill banning legacy admissions at Maryland colleges and universities.

LLLT uses lasers, LEDs, or a combination of both to alter biological activity. The light sources expose cells to low-levels of red and near infrared light (compared to other forms of laser therapy). LLLT makes use of the Grotthuss-Draper law, the first law in photochemistry: light must be absorbed by a chemical substance in order for a photochemical reaction to take place. In the generally accepted LLLT theory that chemical substance is represented by the respiratory enzyme cytochrome c oxidase, which is involved in the electron transport chain in mitochondria. Administering LLLT below the dose range does not appear to be effective.

Sources: en.wikipedia.org

Background from the literature

== Etymology == The term "polymer" derives from Greek πολύς (polus) 'many, much' and μέρος (meros) 'part'. The term was coined in 1833 by Jöns Jacob Berzelius, though with a definition distinct from the modern IUPAC definition. The modern concept of polymers as covalently bonded macromolecular structures was proposed in 1920 by Hermann Staudinger, who spent the next decade finding experimental evidence for this hypothesis.

Belize has a high prevalence of communicable diseases such as respiratory diseases and intestinal illnesses. Under the second term of the Briceño administration, the long-awaited free health care for all Belizeans was launched. The programme is the National Health Insurance Belize and it has been implemented by region until 100% of the population is covered. Health care is practically free and fees if any, are charged from 10% to as low as .5% of total cost on treatments and medications.

Genome-wide analyses of human cancer tissues reveal that a single typical cancer cell may possess roughly 100 mutations in coding regions, 10–20 of which are "driver mutations" that contribute to cancer development. However, chronic inflammation also causes epigenetic changes such as DNA methylations, that are often more common than mutations. Typically, several hundreds to thousands of genes are methylated in a cancer cell (see DNA methylation in cancer). Sites of oxidative damage in chromatin can recruit complexes that contain DNA methyltransferases (DNMTs), a histone deacetylase (SIRT1), and a histone methyltransferase (EZH2), and thus induce DNA methylation. DNA methylation of a CpG island in a promoter region may cause silencing of its downstream gene (see CpG site and regulation of transcription in cancer). DNA repair genes, in particular, are frequently inactivated by methylation in various cancers (see hypermethylation of DNA repair genes in cancer). A 2018 report evaluated the relative importance of mutations and epigenetic alterations in progression to two different types of cancer. This report showed that epigenetic alterations were much more important than mutations in generating gastric cancers (associated with inflammation). However, mutations and epigenetic alterations were of roughly equal importance in generating esophageal squamous cell cancers (associated with tobacco chemicals and acetaldehyde, a product of alcohol metabolism).

=== Full chisel saw chains === The full chisel chain has square-cornered teeth, splitting wood fibers easily in the cut for fast, efficient cutting in clean softwood. Chisel chains have a high kick-back risk due to missing safety chain elements and are more sensitive against dirt. These chains are available for semi-pro (also called pro-sumer) and professional saws.

=== Abortion, sexuality, and family values === In 2016, the Varkey Foundation and Populus conducted an international study examining the attitudes of 20,000 people aged 15 to 21 in twenty countries. They found that just under two thirds of young Americans favored keeping abortion legal, in line with the global average. Gallup polls conducted in 2019 revealed that 62% of people aged 18 to 29—older members of Generation Z and younger Millennials—support giving women access to abortion while 33% opposed. At the national level, Americans are split on the issue of abortion. Many participants in the annual March for Life in Washington, D.C. in the early 2020s are members of Generation Z. However, there is a sex gap in which Gen Z men are significantly less likely to support legal abortion than women and do not think of restrictions on reproductive choices as something important.A 2018 poll conducted by Harris on behalf of the LGBT advocacy group GLAAD found that despite being frequently described as the most tolerant segment of society, people aged 18 to 34—most Millennials and the oldest members of Generation Z—have become less accepting of LGBT individuals compared to previous years.

Sources: en.wikipedia.org

Frequently asked questions

How should the powder be stored?

The lyophilised solid is best kept cold, dry and dark, typically at minus twenty degrees Celsius. Moisture and repeated warming cycles are the main causes of degradation. Solutions prepared from the powder are less stable and are normally used quickly.

Which analytical methods confirm identity?

Reversed-phase liquid chromatography assesses purity, while mass spectrometry confirms molecular mass and detects sequence errors. Amino acid analysis and peptide mapping add structural detail. These techniques are complementary rather than interchangeable.

What is its status in sport and medicines?

It is listed as a prohibited peptide hormone by the World Anti-Doping Agency. No medicines regulator has approved it for human use. Import and sale rules vary by country.

Is melanotan II identical to alpha-melanocyte-stimulating hormone?

No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.

Network